Skeletalis

Angitia

This clinical-stage biotechnology company develops biologic therapies for patients with serious musculoskeletal diseases, including osteoporosis, osteogenesis imperfecta and spinal fusion conditions.

Angitia Biopharmaceuticals

The company develops biologic therapies for patients with serious musculoskeletal diseases, including osteoporosis and osteogenesis imperfecta.

EpiBone

This company grows personalized bone and cartilage grafts from a patient's own stem cells to treat individuals with skeletal defects.

Edgewise

This biopharmaceutical company develops oral small molecule therapies to treat patients with rare skeletal and cardiac muscle diseases.

Radius Health

This biopharmaceutical company develops and commercialises endocrine therapies for patients with osteoporosis and other bone health conditions.

Moroxite F

This company develops regenerative medicine solutions to improve implant anchorage in osteoporotic bone for patients undergoing orthopaedic surgery.

Epicyt Pharma

This company develops pharmaceutical treatments to restore intestinal calcium absorption for patients with osteoporosis or those who have undergone gastric bypass surgery.

IBI

This company develops and manufactures biomimetic bone substitutes for orthopaedic and dental surgeons to support bone tissue regeneration.